182 related articles for article (PubMed ID: 7844541)
41. Age-dependent and strain-related differences of virulence of Semliki Forest virus in mice.
Fleming P
J Gen Virol; 1977 Oct; 37(1):93-105. PubMed ID: 915485
[TBL] [Abstract][Full Text] [Related]
42. Pathogenesis of Semliki Forest virus encephalitis.
Fazakerley JK
J Neurovirol; 2002 Dec; 8 Suppl 2():66-74. PubMed ID: 12491154
[TBL] [Abstract][Full Text] [Related]
43. Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage.
Soilu-Hänninen M; Erälinna JP; Hukkanen V; Röyttä M; Salmi AA; Salonen R
J Virol; 1994 Oct; 68(10):6291-8. PubMed ID: 7916058
[TBL] [Abstract][Full Text] [Related]
44. Amino-terminal sequence analysis of alphavirus polypeptides.
Welch WJ; Sefton BM; Esch FS
J Virol; 1981 Jun; 38(3):968-72. PubMed ID: 7241669
[TBL] [Abstract][Full Text] [Related]
45. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
[TBL] [Abstract][Full Text] [Related]
46. Manipulation of the Semliki Forest virus genome and its potential for vaccine construction.
Atkins GJ; Sheahan BJ; Liljeström P
Mol Biotechnol; 1996 Feb; 5(1):33-8. PubMed ID: 8853014
[TBL] [Abstract][Full Text] [Related]
47. Further studies of macrophages in relationship to avirulent Semliki Forest virus infections.
Oaten SW; Jagelman S; Webb HE
Br J Exp Pathol; 1980 Apr; 61(2):150-5. PubMed ID: 6775662
[TBL] [Abstract][Full Text] [Related]
48. Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus.
Faragher SG; Meek AD; Rice CM; Dalgarno L
Virology; 1988 Apr; 163(2):509-26. PubMed ID: 2833022
[TBL] [Abstract][Full Text] [Related]
49. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
Kim KH; Rümenapf T; Strauss EG; Strauss JH
Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827
[TBL] [Abstract][Full Text] [Related]
50. Pseudo-typed Semliki Forest virus delivers EGFP into neurons.
Jia F; Miao H; Zhu X; Xu F
J Neurovirol; 2017 Apr; 23(2):205-215. PubMed ID: 27739033
[TBL] [Abstract][Full Text] [Related]
51. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
[TBL] [Abstract][Full Text] [Related]
52. Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine.
Risatti GR; Holinka LG; Fernandez Sainz I; Carrillo C; Kutish GF; Lu Z; Zhu J; Rock DL; Borca MV
Virology; 2007 Aug; 364(2):371-82. PubMed ID: 17418362
[TBL] [Abstract][Full Text] [Related]
53. Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.
Boere WA; Harmsen M; Kraaijeveld CA; Snippe H
Arch Virol; 1986; 88(1-2):105-12. PubMed ID: 2420309
[TBL] [Abstract][Full Text] [Related]
54. Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
Donnelly SM; Sheahan BJ; Atkins GJ
Neuropathol Appl Neurobiol; 1997 Jun; 23(3):235-41. PubMed ID: 9223133
[TBL] [Abstract][Full Text] [Related]
55. The effect of cycloleucine on SFV A7(74) infection in mice.
Amor S; Webb HE
Br J Exp Pathol; 1987 Apr; 68(2):225-35. PubMed ID: 3034321
[TBL] [Abstract][Full Text] [Related]
56. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
[TBL] [Abstract][Full Text] [Related]
57. Semliki Forest virus vectors with mutations in the nonstructural protein 2 gene permit extended superinfection of neuronal and non-neuronal cells.
Ehrengruber MU; Goldin AL
J Neurovirol; 2007 Aug; 13(4):353-63. PubMed ID: 17849319
[TBL] [Abstract][Full Text] [Related]
58. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
[TBL] [Abstract][Full Text] [Related]
59. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
[TBL] [Abstract][Full Text] [Related]
60. Expression of Semliki Forest virus capsid protein from SV40 recombinant virus.
Jalanko A
FEBS Lett; 1985 Jul; 186(1):59-64. PubMed ID: 2989005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
